BeStock  

Castle Biosciences CSTL

US equityMarket cap rank #3235Diagnostics & Research
$33.00 −$0.36 (-1.08%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $33.00 0.00%
Open$33.15
Prev close$33.36
Day range$32.77 – $33.72
Volume351.5K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

CSTL Stock News

Headlines matching Castle Biosciences or the CSTL ticker, most recent first.

  • Roth MKM Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 22 Sep 2026 · Direct mention
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40Market news · 3 Aug 2026 · Direct mention
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $36 NegativeMarket news · 31 Jul 2026 · Direct mention
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $57 PositiveMarket news · 31 Jul 2026 · Direct mention
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $52Market news · 7 May 2026 · Direct mention
  • Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $43 NegativeMarket news · 7 May 2026 · Direct mention
  • Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $47Market news · 7 May 2026 · Direct mention
  • KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $35 NegativeMarket news · 29 May 2026 · Direct mention
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40Market news · 13 May 2026 · Direct mention
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 13 May 2026 · Direct mention
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 20 Apr 2026 · Direct mention
  • CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $50Market news · 3 Mar 2026 · Direct mention
  • Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44 PositiveMarket news · 27 Feb 2026 · Direct mention
  • Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $57Market news · 1 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CSTL.

Leave a comment

Scroll to Top